Management of Antipsychotic Therapy in Patients with Schizophrenia

Antipsychotic therapy is the main approach in the treatment of schizophrenia, but there is often irrational use due to inappropriate drug selection, inappropriate dosage, and long-term use without evaluation. Factors that support therapeutic rationality include adherence to clinical guidelines, selection of safer antipsychotics, and optimal management of side effects. Therefore, it is important to evaluate the factors that contribute to rational and irrational therapy in the use of antipsychotics in patients with schizophrenia. This study aims at antipsychotic medication management and factors that cause irrational therapy, as well as evaluating factors that support therapeutic rationality in the use of antipsychotics in schizophrenic patients. This study used a cross-sectional study design involving schizophrenia patients undergoing antipsychotic therapy in a psychiatric hospital. Data were collected through patient medical records and interviews with health workers. Quantitative data were analyzed using descriptive statistics and inferential tests, including chi-square and regression analysis, to determine the association between patient characteristics and antipsychotic selection as well as therapy rationality. The results showed that 26.7% of patients received irrational therapy, with the main causes being inappropriate drug selection (45%), inappropriate dosage (30%), and long-term use without evaluation (25%). Meanwhile, 73.3% of patients received rational therapy, with the main contributing factors being adherence to clinical guidelines (50%), selection of safer antipsychotics (30%), and good side effect management (20%). Irrational antipsychotic therapy remains a significant problem in the management of schizophrenia. Adherence to clinical guidelines and appropriate therapy selection can improve treatment effectiveness and reduce the risk of side effects. Regular evaluation and a multidisciplinary approach are needed to improve the rationality of antipsychotic therapy.

Authors

Institutions

Publication Details

Journal
International Journal of Statistics in Medical Research
Published
2025-04-24
DOI
https://doi.org/10.6000/1929-6029.2025.14.24
Primary Topic
Schizophrenia research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of Antipsychotic Therapy in Patients with Schizophrenia

Trimaya Cahya Mulat, Gemy Nastity Handayany
International Journal of Statistics in Medical Research
Schizophrenia research and treatment
article

Management of Antipsychotic Therapy in Patients with Schizophrenia

Trimaya Cahya Mulat, Gemy Nastity Handayany
article en

Abstract

Antipsychotic therapy is the main approach in the treatment of schizophrenia, but there is often irrational use due to inappropriate drug selection, inappropriate dosage, and long-term use without evaluation. Factors that support therapeutic rationality include adherence to clinical guidelines, selection of safer antipsychotics, and optimal management of side effects. Therefore, it is important to evaluate the factors that contribute to rational and irrational therapy in the use of antipsychotics in patients with schizophrenia. This study aims at antipsychotic medication management and factors that cause irrational therapy, as well as evaluating factors that support therapeutic rationality in the use of antipsychotics in schizophrenic patients. This study used a cross-sectional study design involving schizophrenia patients undergoing antipsychotic therapy in a psychiatric hospital. Data were collected through patient medical records and interviews with health workers. Quantitative data were analyzed using descriptive statistics and inferential tests, including chi-square and regression analysis, to determine the association between patient characteristics and antipsychotic selection as well as therapy rationality. The results showed that 26.7% of patients received irrational therapy, with the main causes being inappropriate drug selection (45%), inappropriate dosage (30%), and long-term use without evaluation (25%). Meanwhile, 73.3% of patients received rational therapy, with the main contributing factors being adherence to clinical guidelines (50%), selection of safer antipsychotics (30%), and good side effect management (20%). Irrational antipsychotic therapy remains a significant problem in the management of schizophrenia. Adherence to clinical guidelines and appropriate therapy selection can improve treatment effectiveness and reduce the risk of side effects. Regular evaluation and a multidisciplinary approach are needed to improve the rationality of antipsychotic therapy.

International Journal of Statistics in Medical ResearchVol. 14
Universitas Pancasakti Makassar (ID), Universitas Islam Makassar (ID)
Openalex Percentile: Top 89%
Schizophrenia research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.